PEPTIDE
Verified ComparisonLast updated: 21 April 2026

MK-677 vs CJC-1295 + Ipamorelin

MK-677 provides oral GH stimulation via ghrelin signalling. The CJC-1295 + ipamorelin combination works on both GHRH and ghrelin receptors. Research literature often favours the dual peptide approach.

Compound A

MK-677 / Ibutamoren

GH Secretagogue

Evidence
3.9/ 5
B+
CJC-1295 + Ipamorelin

Compound B

CJC-1295 + Ipamorelin

Growth Hormone

Evidence
4.4/ 5
A
Editor's note
CJC-1295 + ipamorelin targets two GH pathways; MK-677 is a single oral agent.
CriterionMK-677 / IbutamorenCJC-1295 + Ipamorelin
MechanismGhrelin mimetic (oral)GHRH + GHS-R agonists
Route of administrationOralSubcutaneous injection
Pathways targetedSingle (ghrelin)Dual (GHRH + ghrelin)
Synergy when combinedCan be paired with peptidesAlready synergistic pairing
Research literature preferenceModerate coverageFrequently paired in studies

Frequently asked questions

Research suggests dual-pathway approaches; MK-677 can be paired with GHRH peptides.